Apple Intelligence Cleared for China as Alibaba and Baidu AI Power iPhone Features 
Taiwan Mangoes Head to Europe as Premium Fruit Exports Expand 
Richemont Q1 Sales Beat Forecast as Cartier Demand Drives Strong Growth 
Paramount-Warner Bros. Discovery Merger Faces Lawsuit From 12 States 
Samsung to Launch First Yongin Chip Plant by 2029 as South Korea Speeds Up Semiconductor Hub 
SK Hynix Stock Soars as AI Memory Demand Outlook Fuels Chip Rally 
Nvidia Tightens AI Chip Sales in Asia With Stricter Customer Approval Process 
DeepSeek Eyes China IPO as AI Startup Seeks $71 Billion Valuation in New Funding Round 
Mastercard Explores Sale of Majority Stake in UK Payments Firm Vocalink: Report 
Australia Flags Child Safety Gaps at Apple, Meta, Google Over Online Sexual Extortion 
Morgan Stanley Says China’s Reusable Rocket Progress Poses Long-Term Challenge to SpaceX 
SK Hynix Shares Drop After Strong Nasdaq Debut Despite $26 Billion ADR Listing 
Arm Stock Falls After HSBC Downgrade, Citing Limited Near-Term AI Upside 
Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business 
SoftBank Corp Partners With Sierra to Expand AI Customer Support Across Japan 
Stellantis Q2 Vehicle Shipments Rise 10% as North America Drives Growth 
ASML Raises 2026 Outlook as AI Chip Demand Lifts Q2 Earnings 
PLEASANTON, Calif., Jan. 13, 2016 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:BABY) today announced that the Company will release its 2015 fourth quarter financial results before the market opens on Wednesday, January 27th. Natus management will host an investment-community conference call the same day beginning at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time) to discuss those results and to answer questions.
Individuals interested in listening to the conference call may do so by dialing 1-888-765-3164 for domestic callers, or 1-503-406-4075 for international callers, and entering reservation code 23993319. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 1-855-859-2056 for domestic callers, or 1-404-537-3406 for international callers, and entering reservation code 23993319.
The conference call also will be available real-time via the Internet at http://investor.natus.com and a recording of the call will be available on the Company's Web site for 90 days following the completion of the call.
About Natus Medical Incorporated
Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders.
Additional information about Natus Medical can be found at www.natus.com.
COMPANY CONTACT: Natus Medical Incorporated Jonathan A. Kennedy Sr. Vice President and Chief Financial Officer (925) 223-6700 [email protected]
